erythromycin has been researched along with morphine in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (13.64) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 10 (45.45) | 29.6817 |
2010's | 7 (31.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fischer, H; Huwyler, J; Poli, S; Schwab, D; Tabatabaei, A | 1 |
Jolivette, LJ; Ward, KW | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hiller, FC; Olsen, KM | 1 |
Jackson, DM | 1 |
Planas, J; Torralba, A; Vinardell, P | 1 |
Akkermans, LM; Gooszen, HG; Nieuwenhuijs, VB; van Duijvenbode-Beumer, H; Verheem, A; Verhoef, J; Visser, MR | 1 |
Dkhar, SA; Shashindran, CH; Shewade, DG; Suchitra, AD | 1 |
Boden, GH; Fisher, RS; Gonlachanvit, S; Hsu, CW; Knight, LC; Maurer, AH; Parkman, HP | 1 |
Cynshi, O; Itoh, Z; Kamei, K; Koga, H; Muramatsu, H; Omura, S; Ozaki, K; Sudo, H; Takanashi, H; Yogo, K | 1 |
Khawam, E; Lackner, JM; Moore, J; Mreyoud, A; Rozov-Ung, I; Semler, JR; Sitrin, MD; Wilding, GE | 1 |
Danielian, P | 1 |
1 review(s) available for erythromycin and morphine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for erythromycin and morphine
Article | Year |
---|---|
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Bacterial Agents; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Morphine; Placebo Effect; Postprandial Period; Radionuclide Imaging; Stomach | 2003 |
Detection of drug effects on gastric emptying and contractility using a wireless motility capsule.
Topics: Adult; Aged; Body Temperature; Capsule Endoscopy; Erythromycin; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Ambulatory; Morphine; Muscle Contraction; Muscle, Smooth; Pressure; Sodium Chloride; Stomach; Time Factors; Wireless Technology; Young Adult | 2014 |
19 other study(ies) available for erythromycin and morphine
Article | Year |
---|---|
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Mice; Models, Molecular; Rhodamines; Species Specificity; Swine | 2003 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Management of tetanus.
Topics: Aged; Aged, 80 and over; Chlorpromazine; Clostridium tetani; Darkness; Diazepam; Erythromycin; Female; Humans; Intensive Care Units; Middle Aged; Morphine; Ranitidine; Tetanus; Tetanus Toxoid | 1987 |
Thermal and chemical burns of the head and neck.
Topics: Aerosols; Bacitracin; Burns; Burns, Chemical; Child, Preschool; Cloxacillin; Erythromycin; Eye Burns; Facial Injuries; Female; Humans; Male; Morphine; Neomycin; Polymyxins; Skin Transplantation; Skull; Streptococcal Infections; Surgery, Plastic; Transplantation, Homologous | 1965 |
Inhibition of erythromycin lactobionate-induced writhing by analgesic drugs.
Topics: Analgesics; Animals; Aspirin; Codeine; Dextropropoxyphene; Erythromycin; Indomethacin; Male; Mice; Morphine; Nalorphine; Naloxone; Pain; Phenylbutazone | 1980 |
The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats.
Topics: Animals; Drug Interactions; Duodenum; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Ileum; Intestine, Small; Male; Morphine; Octreotide; Rats; Rats, Sprague-Dawley | 1999 |
Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
Topics: Animals; Benzamides; Cisapride; Domperidone; Drug Interactions; Erythromycin; Female; Gastric Emptying; Gastrointestinal Transit; Male; Metoclopramide; Mice; Morphine; Morpholines | 2003 |
Mitemcinal (GM-611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools.
Topics: Animals; Constipation; Defecation; Diarrhea; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Erythromycin; Gastrointestinal Agents; Morphine; Motilin; Rabbits; Reference Values | 2007 |
Erythromycin, motilin, and meconium.
Topics: Erythromycin; Female; Humans; Infant, Newborn; Meconium; Motilin; Pregnancy; Ureaplasma Infections; Ureaplasma urealyticum | 1992 |